Ken Griffin Night Hawk Biosciences, Inc. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$0.5 - $0.72 $850 - $1,224	1,700 Added 188.89%	2,600 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.62 - $0.87 $2,480 - $3,480	-4,000 Reduced 81.63%	900 $0
Q1 2023 May 15, 2023	SELL	$0.83 - $1.24 $11,620 - $17,360	-14,000 Reduced 74.07%	4,900 $4,000
Q4 2022 Feb 14, 2023	BUY	$0.77 - $1.62 $4,004 - $8,424	5,200 Added 37.96%	18,900 $15,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $1,790 - $2,960	-1,000 Reduced 6.8%	13,700 $24,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.